155 related articles for article (PubMed ID: 5311277)
1. Distribution of inhaled 239PuO2 particles within pulmonary macrophages. BNWL-1050.
Sanders CL
BNWL Rep; 1970 Jan; ():3.35+. PubMed ID: 5311277
[No Abstract] [Full Text] [Related]
2. Cellular interactions with plutonium particles. BNWL-1221.
BNWL Rep; 1970 Feb; ():5.1+. PubMed ID: 5311145
[No Abstract] [Full Text] [Related]
3. The ultrastructure of peritoneal mononuclear phagocytes exposed in vivo to 239PuO2 particles. BNWL-714.
Sanders CL; Adee RR
BNWL Rep; 1968 May; ():6.20-6+. PubMed ID: 5307099
[No Abstract] [Full Text] [Related]
4. Maintenance of phagocytic function following 239PuO2 particle administration. BNWL-1050.
Sanders CL
BNWL Rep; 1970 Jan; ():3.29+. PubMed ID: 5311276
[No Abstract] [Full Text] [Related]
5. Removal of inhaled 239PuO2 from rats. BNWL-1050.
Dilley JV
BNWL Rep; 1970 Jan; ():5.11+. PubMed ID: 5311293
[No Abstract] [Full Text] [Related]
6. Removal of inhaled 239PuO2 by lung washing. BNWL-1050.
Sanders CL
BNWL Rep; 1970 Jan; ():5.18+. PubMed ID: 5311295
[No Abstract] [Full Text] [Related]
7. The disposition of inhaled plutonium. IV. Long-term 239PuO2 studies. BNWL-1221.
BNWL Rep; 1970 Feb; ():4.13+. PubMed ID: 5311143
[No Abstract] [Full Text] [Related]
8. The ultrastructure of mononuclear phagocytes following intraperitoneal administration of 239PuO2 particles.
Sanders CL; Adee RR
J Reticuloendothel Soc; 1969 Feb; 6(1):1-23. PubMed ID: 5766369
[No Abstract] [Full Text] [Related]
9. Effect of DTPA and calcium on intraperitoneally injected 239PuO2 particles. BNWL-714.
Sanders CL; Bair WJ
BNWL Rep; 1968 May; ():6.17-6+. PubMed ID: 5307098
[No Abstract] [Full Text] [Related]
10. Phagocytosis and translocation of intraperitoneally injected 239PuO2 and 238PuO2 particles. BNWL-714.
Sanders CL
BNWL Rep; 1968 May; ():6.13-6+. PubMed ID: 5307097
[No Abstract] [Full Text] [Related]
11. Effect of electro-aerosol inhalation on pulmonary clearance of 239PuO2 in rats. BNWL-1050.
Wehner AP
BNWL Rep; 1970 Jan; ():5.19+. PubMed ID: 5311296
[No Abstract] [Full Text] [Related]
12. Chronic effects of inhaled 239PuO2 in beagles. BNWL-1050.
Park JF; Bair WJ; Howard EB; Clarke WJ
BNWL Rep; 1970 Jan; ():3.3+. PubMed ID: 5311278
[No Abstract] [Full Text] [Related]
13. Promotion of pulmonary carcinogenesis by plutonium particle aggregation following inhalation of 239PuO2.
Sanders CL; McDonald KE; Lauhala KE
Radiat Res; 1988 Dec; 116(3):393-405. PubMed ID: 2974596
[TBL] [Abstract][Full Text] [Related]
14. The disposition of inhaled plutonium. I. Comparison of chemical forms. BNWL-1221.
BNWL Rep; 1970 Feb; ():2.1-2+. PubMed ID: 5311141
[No Abstract] [Full Text] [Related]
15. Concentration of 239PuO2 particles within phagocytic cells. BNWL-1050.
Sanders CL
BNWL Rep; 1970 Jan; ():3.25+. PubMed ID: 5311275
[No Abstract] [Full Text] [Related]
16. Distribution of alpha energy in alveoli following deposition of 239PuO2 particles. BNWL-1050.
Sanders CL; Dionne PJ
BNWL Rep; 1970 Jan; ():3.40+. PubMed ID: 5311279
[No Abstract] [Full Text] [Related]
17. Chronic effects of inhaled 239PuO2 in beagles. BNWL-714.
Park JF; Clarke WJ; Bair WJ
BNWL Rep; 1968 May; ():3.3-3+. PubMed ID: 5307077
[No Abstract] [Full Text] [Related]
18. The disposition of inhaled plutonium. II. Effect of particle size. 23PuO2--short term studies. BNWL-1221.
BNWL Rep; 1970 Feb; ():3.1-3+. PubMed ID: 5311142
[No Abstract] [Full Text] [Related]
19. The disposition of inhaled plutonium. 3. Pulmonary retention of 238Pu microspheres. BNWL-1221.
BNWL Rep; 1970 Feb; ():4.1-4+. PubMed ID: 5311144
[No Abstract] [Full Text] [Related]
20. Biological effects of inhaled plutonium. BNWL-1221.
BNWL Rep; 1970 Feb; ():6.1+. PubMed ID: 5311146
[No Abstract] [Full Text] [Related]
[Next] [New Search]
